Dr. Cheuk Ka Leung Daniel - Paediatrics
Specialist in Paediatrics
Highlights
- MCHK RegisteredVerified
- Specialist in PaediatricsBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Paediatricians · Medical degree 1998
- InsuranceBeing compiled｜See details
About
Dr. Cheuk Ka Leung Daniel is a registered Paediatrics specialist in Hong Kong.
Education
Specialist in Paediatrics
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1998
Hong Kong Academy of Medicine fellowships
- FHKCPaedFellow, Hong Kong College of Paediatricians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Cheuk Ka Leung Daniel? Claim page and update insurance →
Hospital Affiliations
Referrals available to these hospitals
FAQ
Is Dr. Cheuk Ka Leung Daniel any good?
Dr. Cheuk Ka Leung Daniel is a registered Paediatrics specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Cheuk Ka Leung Daniel do?
Dr. Cheuk Ka Leung Daniel practises in Paediatrics.
Are you Dr. Cheuk Ka Leung Daniel? Claim this page to update and manage.
ClaimResearch and publications
61 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Memory T Cell Donor Lymphocyte Infusion as a Treatment for Viral Infection After Pediatric Haploidentical Hematopoietic Stem Cell Transplant.Transplantation and cellular therapy · 2026
- Excellent Outcome of 1-Day Nonmyeloablative Salvage Regimen for Pediatric Patients with Graft Failure following Haploidentical Hematopoietic Stem Cell Transplantation.Transplantation and cellular therapy · 2026
- Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia.British journal of haematology · 2025
- A Modified Three-Step Haploidentical Transplantation With TCRαβ/CD62L Depletion for Epstein-Barr Virus Hemophagocytic Lymphohistiocytosis and Natural Killer-Cell Lymphoproliferative Disease.Pediatric blood & cancer · 2025
- Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
- Autologous hematopoietic stem cell transplantation followed by quadruple immunotherapy with dinutuximab beta, sargramostim, aldesleukin, and spironolactone for relapsed metastatic retinoblastoma.Pediatric blood & cancer · 2024
- Case report: Therapy-related myeloid neoplasms in three pediatric cases with medulloblastoma.Frontiers in oncology · 2024
- High infection rates and risk-adapted prevention strategies in contemporary pediatric allogeneic hematopoietic stem cell transplantation.Pediatric discovery · 2024
- Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome.Blood advances · 2023
- Remote Ischemic Conditioning in Pediatric Cancer Patients Receiving Anthracycline Chemotherapy: A Sham-Controlled Single-Blind Randomized Trial.JACC. CardioOncology · 2023
- Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia.British journal of haematology · 2023
- Blinatumomab with donor lymphocyte infusions post haploidentical hematopoietic stem cell transplantation as salvage therapy for relapsed refractory acute lymphoblastic leukemia post chimeric antigen receptor T-cell therapy.Pediatric blood & cancer · 2023
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer